Skye Bioscience outlines 2026 clinical milestones for obesity drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/12/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Skye Bioscience outlines 2026 clinical milestones for obesity drug
(NASDAQ: SKYE) Delayed: 2.04 -0.04 (1.92%)
Previous Close $2.08    52 Week High $ 
Open $2.08    52 Week Low $ 
Day High $2.09    P/E N/A 
Day Low $1.99    EPS $ 
Volume 66,180